Richard Scott Blackley Sells 100,000 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 100,000 shares of the stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $23.16, for a total value of $2,316,000.00. Following the completion of the transaction, the chief financial officer directly owned 1,216,660 shares of the company’s stock, valued at $28,177,845.60. This represents a 7.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oscar Health Stock Up 8.8%

Shares of NYSE:OSCR traded up $2.05 during trading on Monday, hitting $25.37. The stock had a trading volume of 13,381,610 shares, compared to its average volume of 7,963,523. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $25.58. The company has a market capitalization of $7.65 billion, a PE ratio of -43.01, a PEG ratio of 1.63 and a beta of 2.34. The firm’s fifty day moving average is $15.51 and its 200 day moving average is $15.40. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same quarter last year, the company earned $0.92 EPS. The firm’s revenue for the quarter was up 52.6% on a year-over-year basis. Analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Institutional Trading of Oscar Health

Several institutional investors have recently added to or reduced their stakes in the business. OneDigital Investment Advisors LLC boosted its stake in Oscar Health by 0.6% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock valued at $2,617,000 after purchasing an additional 779 shares during the last quarter. Focus Partners Wealth boosted its stake in Oscar Health by 1.4% during the 3rd quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after purchasing an additional 824 shares during the last quarter. Equitable Holdings Inc. boosted its stake in Oscar Health by 7.0% during the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after purchasing an additional 850 shares during the last quarter. Captrust Financial Advisors boosted its stake in Oscar Health by 2.0% during the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after purchasing an additional 895 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC boosted its stake in Oscar Health by 5.6% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock valued at $255,000 after purchasing an additional 938 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on OSCR shares. Barclays raised their price objective on Oscar Health from $18.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Wolfe Research started coverage on Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating for the company. Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and raised their price objective for the company from $10.00 to $16.00 in a research report on Monday, April 20th. Wall Street Zen raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Saturday, May 9th. Finally, Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective for the company in a research report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $18.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.